Transcatheter Aortic Valve Replacement (TAVR) Devices Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Global Transcatheter Aortic Valve Replacement (TAVR) Devices Market by Type of Procedure (Transfemoral, Transapical, Transaortic, Subclavian, Others),and Geography

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

The global Transcatheter Aortic Valve Replacement (TAVR) Devices Market size was estimated at USD 11.2 Bn in 2021, growing at a CAGR of 20.8% during the forecast period 2021-2027. TAVR devises Market is a new technology has recently shown to improve survival and quality of life in patients with severe symptomatic aortic stenosis who are not surgical candidates. The development and design of transcatheter valves has been ongoing for the past 20 years and TAVR has been approved recently by GDA for treatment of aortic stenosis in patients who are not surgical candidates. Transcatheter Aortic Valve Replacement (TAVR) Devices Market players are focusing on investments in R&D to develop and launch various new and technologically advanced devices for making heart valve procedures safer and more effective and strengthening their positions in market. For instance, trans catheter aortic valve replacement or transcatheter aortic valve implantation has become novel procedures for patients who are considered high risk for standard valve replacement therapy. Apart from this, companies also focusing on mergers and acquisitions to enhance their market share. For instance in 2016, Edwards Lifesciences Corporation agreed to acquire Valtech Cardio Ltd., for trans catheter repair of mitral and tricuspid valves. The revised report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.

Transcatheter Aortic Valve Replacement (TAVR) Devices Market

MARKET SUMMARY
-
20.8% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 20.8% CAGR
  • Largest Market– North America
  • Fastest Growing Market– Europe

Transcatheter Aortic Valve Replacement (TAVR) Devi

  • The report on global Transcatheter Aortic Valve Replacement (TAVR) Devices Market gives historical, current, and future market sizes (US$ Bn) basis on the type of procedure, end user and geographical regions.
  • Global Transcatheter Aortic Valve Replacement (TAVR) Devices Market gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Edwards Lifesciences Corporation (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Abbot Laboratories (U.S.)
  • Medtronic Plc. (U.S)
  • Jena Valve Technology, Inc. (U.S)
  • Bracco SpA. (Italy)
Drivers And Restraints

Transcatheter Aortic Valve Replacement (TAVR) Devices Market

Pine derived chemicals has found its positions in various industries owing to its versatility. Paints & coatings, adhesives & sealants, surfactants, and printing inks are some of the industries where pine chemicals are used to a greater extent. Pine chemicals is predominantly used for paints & coatings and is projected to lead in terms of market revenue owing to the rising development, usage of pine chemicals in bulky amount, increasing environmental regulations, increasing awareness of consumers about the product.


North-America got significant share

Transcatheter Aortic Valve Replacement (TAVR) Devices Market

Geographically, global Transcatheter Aortic Valve Replacement (TAVR) Devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America market is dominating among all regions. Over five million people in U.S. are diagnosed with heart valve disease each year. Europe Transcatheter Aortic Valve Replacement (TAVR) Devices market for expected to grow at significant rate due to technological advancements, increase in awareness and acceptance of novel replacement devices for cardiac disorders. Emerging economies of Asia-Pacific region such as China and India expected to show significant growth in the market due to medical tourism, increasing patients with heart diseases and significant changing in lifestyle

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market  and forecast.
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Segmentation

Transcatheter Aortic Valve Replacement (TAVR) Devices Market


Location

GEOGRAPHY

Frequently Asked Questions

North America is expected to dominate the Transcatheter Aortic Valve Replacement (TAVR) Devices Marketover the forecasted period.

Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), Abbot Laboratories (U.S.)Medtronic Plc. (U.S), Jena Valve Technology, Inc. (U.S)


Report

Table Of Content

1. Executive Summary
2. Global Transcatheter Aortic Valve Replacement (TAVR) Market Introduction
2.1. Global Transcatheter Aortic Valve Replacement (TAVR) Market – Taxonomy
2.2. Global Transcatheter Aortic Valve Replacement (TAVR) Market –Definitions
2.2.1. By Procedure
2.2.2. By Region
3. Global Transcatheter Aortic Valve Replacement (TAVR) Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Transcatheter Aortic Valve Replacement (TAVR) Market Dynamic Factors – Impact Analysis
3.6. Impact of COVID 19 on The Market
3.7. Three Forecast Scenarios – Pessimistic, Conservative, and Opportunistic
3.8. Mapping Market Player’s Activities
3.9. Recent Key Developments
3.10. Financial Status of the Market Players
3.11. Recent Acquisitions, Collaborations, and Mergers
4. Global Transcatheter Aortic Valve Replacement (TAVR) Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Transcatheter Aortic Valve Replacement (TAVR) Market Forecast, By Procedure, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.1. Transfemoral
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Transapical
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Transaortic
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Subclavian
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Transcatheter Aortic Valve Replacement (TAVR) Market Forecast, By Region, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.1. North America
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Europe
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Asia-Pacific
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Latin America
6.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Middle East and Africa
6.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Global Transcatheter Aortic Valve Replacement (TAVR) Market – Opportunity Analysis Index, By Procedure, and Region, 2022 – 2028
7. North America Transcatheter Aortic Valve Replacement (TAVR) Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
7.1. Procedure Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
7.1.1. Transfemoral
7.1.2. Transapical
7.1.3. Transaortic
7.1.4. Subclavian
7.1.5. Others
7.2. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
7.2.1. U.S.
7.2.2. Canada
7.3. North America Transcatheter Aortic Valve Replacement (TAVR) Market – Opportunity Analysis Index, By Procedure, and Country, 2022 – 2028
7.4. North America Transcatheter Aortic Valve Replacement (TAVR) Market Dynamics – Trends
8. Europe Transcatheter Aortic Valve Replacement (TAVR) Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
8.1. Procedure Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
8.1.1. Transfemoral
8.1.2. Transapical
8.1.3. Transaortic
8.1.4. Subclavian
8.1.5. Others
8.2. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
8.2.1. Germany
8.2.2. UK
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Europe Transcatheter Aortic Valve Replacement (TAVR) Market – Opportunity Analysis Index, By Procedure, and Country, 2022 – 2028
8.4. Europe Transcatheter Aortic Valve Replacement (TAVR) Market Dynamics – Trends
9. Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
9.1. Procedure Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
9.1.1. Transfemoral
9.1.2. Transapical
9.1.3. Transaortic
9.1.4. Subclavian
9.1.5. Others
9.2. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
9.2.1. Japan
9.2.2. China
9.2.3. India
9.2.4. ASEAN
9.2.5. Rest of Asia-Pacific
9.3. Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market – Opportunity Analysis Index, By Procedure, and Country, 2022 – 2028
9.4. Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Dynamics – Trends
10. Latin America Transcatheter Aortic Valve Replacement (TAVR) Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
10.1. Procedure Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Transfemoral
10.1.2. Transapical
10.1.3. Transaortic
10.1.4. Subclavian
10.1.5. Others
10.2. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
10.2.1. Brazil
10.2.2. Argentina
10.2.3. Rest of Latin America
10.3. Latin America Transcatheter Aortic Valve Replacement (TAVR) Market – Opportunity Analysis Index, By Procedure, and Country, 2022 – 2028
10.4. Latin America Transcatheter Aortic Valve Replacement (TAVR) Market Dynamics – Trends
11. Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Million)
11.1. Procedure Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Transfemoral
11.1.2. Transapical
11.1.3. Transaortic
11.1.4. Subclavian
11.1.5. Others
11.2. Country Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%)
11.2.1. Saudi Arabia
11.2.2. GCC Countries
11.2.3. South Africa
11.2.4. Rest of MEA
11.3. MEA Transcatheter Aortic Valve Replacement (TAVR) Market – Opportunity Analysis Index, By Procedure, and Country, 2022 – 2028
11.4. MEA Transcatheter Aortic Valve Replacement (TAVR) Market Dynamics – Trends
12. Competition Landscape 
12.1. Strategic Dashboard of Top Market Players
12.2. Company Profiles (Introduction, Financial Analysis, Procedure Offerings, Key Developments, Strategies, and SWOT Analysis)
12.2.1. Medtronic plc
12.2.2. Boston Scientific Corporation
12.2.3. Edwards Lifesciences Corporation
12.2.4. Abbott Laboratories
12.2.5. Bracco
12.2.6. JenaValve Technology
12.2.7. Meril Life Sciences
13. Research Methodology
14. Key Assumptions and Acronyms

Report

Company Profile

  • Edwards Lifesciences Corporation (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Abbot Laboratories (U.S.)
  • Medtronic Plc. (U.S)
  • Jena Valve Technology, Inc. (U.S)
  • Bracco SpA. (Italy)
  • Direct Flow medical, Inc. (U.S)
  • Meril Life Sciences Pvt. Ltd. (India)

Description

The global Transcatheter Aortic Valve Replacement (TAVR) Devices Market size was estimated at USD 11.2 Bn in 2021, growing at a CAGR of 20.8% during the forecast period 2021-2027. TAVR devises Market is a new technology has recently shown to improve survival and quality of life in patients with severe symptomatic aortic stenosis who are not surgical candidates. The development and design of transcatheter valves has been ongoing for the past 20 years and TAVR has been approved recently by GDA for treatment of aortic stenosis in patients who are not surgical candidates. Transcatheter Aortic Valve Replacement (TAVR) Devices Market players are focusing on investments in R&D to develop and launch various new and technologically advanced devices for making heart valve procedures safer and more effective and strengthening their positions in market. For instance, trans catheter aortic valve replacement or transcatheter aortic valve implantation has become novel procedures for patients who are considered high risk for standard valve replacement therapy. Apart from this, companies also focusing on mergers and acquisitions to enhance their market share. For instance in 2016, Edwards Lifesciences Corporation agreed to acquire Valtech Cardio Ltd., for trans catheter repair of mitral and tricuspid valves. The revised report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX